Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- LIFE
- Price
- -
- Stock movement up
- +0.12 (6.45%)
- Company name
- aTyr Pharma Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 136.64M
- Ent value
- 158.80M
- Price/Sales
- 27.87
- Price/Book
- 1.62
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -43.36%
- 1 year return
- -13.91%
- 3 year return
- -24.88%
- 5 year return
- -18.34%
- 10 year return
- -
Last updated: 2024-12-17
iO Charts is a Seeking Alpha partner
DIVIDENDS
LIFE does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 27.87 |
| Price to Book | 1.62 |
| EV to Sales | 32.39 |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 69.01M |
| EPS (TTM) | - |
| FCF per share (TTM) | - |
Income statement
Loading...
Income statement data
| Revenue (TTM) | - |
| Gross profit (TTM) | - |
| Operating income (TTM) | - |
| Net income (TTM) | - |
| EPS (TTM) | - |
| EPS (1y forward) | -0.75 |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 6.81M |
| Net receivables | 2.48M |
| Total current assets | 96.92M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 12.99M |
| Total assets | 113.25M |
| Accounts payable | 4.89M |
| Short/Current long term debt | 14.13M |
| Total current liabilities | 15.98M |
| Total liabilities | 28.97M |
| Shareholder's equity | 84.28M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | - |
| Capital expenditures (TTM) | - |
| Free cash flow (TTM) | - |
| Dividends paid (TTM) | - |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | - |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| LIFE | S&P500 | |
| Current price drop from All-time high | -99.49% | -0.12% |
| Highest price drop | -99.72% | -19.00% |
| Date of highest drop | 14 Nov 2023 | 8 Apr 2025 |
| Avg drop from high | -91.79% | -2.76% |
| Avg time to new high | 254 days | 5 days |
| Max time to new high | 2270 days | 89 days |
COMPANY DETAILS
Marketcap
136.64M
Marketcap category
Small-cap
Description
aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. Its lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase III clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. The company is developing ATYR0101, a fusion protein derived from a domain of aspartyl-tRNA synthetase that is in preclinical development for the treatment of fibrosis; and ATYR0750, a domain of alanyl-tRNA synthetase for the treatment of liver disorders. It has collaboration and license agreement with Kyorin Pharmaceutical Co., Ltd. for the development and commercialization of efzofitimod for ILDs in Japan. aTyr Pharma, Inc. was incorporated in 2005 and is headquartered in San Diego, California.
Employees
56
Website
Investor relations
-
SEC filings
CEO
Sanjay S. Shukla
Country
USA
City
San Diego
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner